scholarly journals P2095SIRT4 regulates fatty acid utilisation and cardiac function in the normal and diabetic heart

2017 ◽  
Vol 38 (suppl_1) ◽  
Author(s):  
M.E. Hoelscher ◽  
C. Koentges ◽  
C. Muesse ◽  
S. Birkle ◽  
M.M. Hoffmann ◽  
...  
2018 ◽  
Vol 124 ◽  
pp. 99
Author(s):  
Qutuba G. Karwi ◽  
Liyan Zhang ◽  
Abhishek Gupta ◽  
Arata Fukushima ◽  
Vaibhav Patel ◽  
...  

2008 ◽  
Vol 44 (4) ◽  
pp. 761
Author(s):  
J. McCarthy ◽  
A. Lochner ◽  
S. Genade ◽  
P. Ping ◽  
M.F. Essop ◽  
...  

2010 ◽  
Vol 12 (4) ◽  
pp. 323-330 ◽  
Author(s):  
Ching-Yi Chen ◽  
Hsiu-Ching Hsu ◽  
Bai-Chin Lee ◽  
Hung-Ju Lin ◽  
Ying-Hsien Chen ◽  
...  

2019 ◽  
Vol 317 (2) ◽  
pp. H290-H299 ◽  
Author(s):  
Kirsten M. Jansen ◽  
Sonia Moreno ◽  
Pablo M. Garcia-Roves ◽  
Terje S. Larsen

The aim of this study was to find out whether dietary supplementation with Calanus oil (a novel marine oil) or infusion of exenatide (an incretin mimetic) could counteract obesity-induced alterations in myocardial metabolism and improve postischemic recovery of left ventricular (LV) function. Female C57bl/6J mice received high-fat diet (HFD, 45% energy from fat) for 12 wk followed by 8-wk feeding with nonsupplemented HFD, HFD supplemented with 2% Calanus oil, or HFD plus exenatide infusion (10 µg·kg−1·day−1). A lean control group was included, receiving normal chow throughout the whole period. Fatty acid and glucose oxidation was measured in ex vivo perfused hearts during baseline conditions, while LV function was assessed with an intraventricular fluid-filled balloon before and after 20 min of global ischemia. HFD-fed mice receiving Calanus oil or exenatide showed less intra-abdominal fat deposition than mice receiving nonsupplemented HFD. Both treatments prevented the HFD-induced decline in myocardial glucose oxidation. Somewhat surprising, recovery of LV function was apparently better in hearts from mice fed nonsupplemented HFD relative to hearts from mice fed normal chow. More importantly however, postischemic recovery of hearts from mice receiving HFD with Calanus oil was superior to that of mice receiving nonsupplemented HFD and mice receiving HFD with exenatide, as expressed by better pressure development, contractility, and relaxation properties. In summary, dietary Calanus oil and administration of exenatide counteracted obesity-induced derangements of myocardial metabolism. Calanus oil also protected the heart from ischemia, which could have implications for the prevention of obesity-related cardiac disease. NEW & NOTEWORTHY This article describes for the first time that dietary supplementation with a low amount (2%) of a novel marine oil (Calanus oil) in mice is able to prevent the overreliance of fatty acid oxidation for energy production during obesity. The same effect was observed with infusion of the incretin mimetic, exanatide. The improvement in myocardial metabolism in Calanus oil-treated mice was accompanied by a significantly better recovery of cardiac performance following ischemia-reperfusion. Listen to this article’s corresponding podcast at https://ajpheart.podbean.com/e/dietary-calanus-oil-energy-metabolism-and-cardiac-function/ .


Diabetes ◽  
2020 ◽  
Vol 69 (10) ◽  
pp. 2054-2057
Author(s):  
Jessica Gambardella ◽  
Angela Lombardi ◽  
Gaetano Santulli

2018 ◽  
Vol 57 (24) ◽  
pp. 3593-3596 ◽  
Author(s):  
Mai Kaneko ◽  
Hirotaka Fukasawa ◽  
Kento Ishibuchi ◽  
Hiroki Niwa ◽  
Hideo Yasuda ◽  
...  

2008 ◽  
Vol 295 (2) ◽  
pp. H842-H850 ◽  
Author(s):  
Pablo F. Soto ◽  
Pilar Herrero ◽  
Kenneth B. Schechtman ◽  
Alan D. Waggoner ◽  
Jeffrey M. Baumstark ◽  
...  

Aging is associated with decreases in aerobic capacity, cardiac function, and insulin sensitivity as well as alterations in myocardial substrate metabolism. Endurance exercise training (EET) improves cardiac function in a gender-specific manner, and EET has been shown to improve whole body glucose tolerance, but its effects on myocardial metabolism are unclear. Accordingly, we studied the effect of EET on myocardial substrate metabolism in older men and women. Twelve healthy older individuals (age: 60–75 yr; 6 men and 6 women) underwent PET with [15O]water, [11C]acetate, [11C]glucose, and [11C]palmitate for the assessment of myocardial blood flow (MBF), myocardial O2 consumption (MV̇o2), myocardial glucose utilization (MGU), and myocardial fatty acid utilization (MFAU), respectively, at rest and during dobutamine infusion (10 μg·kg−1·min−1). Measurements were repeated after 11 mo of EET. Maximal O2 uptake (V̇o2max) increased ( P = 0.005) after EET. MBF was unaffected by training, as was resting MV̇o2; however, posttraining dobutamine MV̇o2 was significantly higher ( P = 0.05), as was MGU ( P < 0.04). Although overall dobutamine MFAU was unchanged, posttraining dobutamine MFAU increased in women ( P = 0.01) but decreased in men ( P = 0.03). Thus, EET in older individuals improves the catecholamine response of myocardial glucose metabolism. Moreover, gender differences exist in the myocardial fatty acid metabolic response to training. These findings suggest a role for altered myocardial substrate metabolism in modulating the cardiovascular benefits of EET in older individuals.


Sign in / Sign up

Export Citation Format

Share Document